{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:17:09Z","timestamp":1791818229528,"version":"4.3.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009268","name":"Alport Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001468","name":"ASF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/ndt\/gfx246","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T19:11:24Z","timestamp":1498677084000},"page":"214-223","source":"Crossref","is-referenced-by-count":43,"title":["STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model"],"prefix":"10.1093","volume":"33","author":[{"given":"Tsubasa","family":"Yokota","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Omachi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"},{"name":"Program for Leading Graduate School Health Life Science: Interdisciplinary and Glocal Oriented Program, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Suico","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Kamura","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"},{"name":"Program for Leading Graduate School Health Life Science: Interdisciplinary and Glocal Oriented Program, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Motomura","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"},{"name":"Program for Leading Graduate School Health Life Science: Interdisciplinary and Glocal Oriented Program, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kaseda","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"},{"name":"Program for Leading Graduate School Health Life Science: Interdisciplinary and Glocal Oriented Program, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kuwazuru","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Takeo","sequence":"additional","affiliation":[{"name":"Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Nakagata","sequence":"additional","affiliation":[{"name":"Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Shuto","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Kumamoto, Japan"},{"name":"Program for Leading Graduate School Health Life Science: Interdisciplinary and Glocal Oriented Program, Kumamoto University, Kumamoto City, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"key\n\t\t\t\t20180328162557_gfx246-B1","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's syndrome, Goodpasture's syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ki.2009.324","article-title":"Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease","volume":"76","author":"Meehan","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2009.223","article-title":"Treatment of Alport syndrome: beyond animal models","volume":"76","author":"Gross","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B6","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1113\/jphysiol.2014.274449","article-title":"Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment","volume":"592","author":"Savige","year":"2014","journal-title":"J Physiol (Lond)"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B7","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/TP.0b013e3181739d25","article-title":"STAT3: an important regulator of multiple cytokine functions","volume":"85","author":"Stepkowski","year":"2008","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B8","doi-asserted-by":"crossref","first-page":"34182","DOI":"10.1074\/jbc.M102859200","article-title":"Global gene expression analysis reveals a role for the alpha 1 integrin in renal pathogenesis","volume":"276","author":"Sampson","year":"2001","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B9","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pmed.0030100","article-title":"Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease","volume":"3","author":"Zeisberg","year":"2006","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B10","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1681\/ASN.2016060603","article-title":"Beyond EMT: epithelial STAT3 as a central regulator of fibrogenesis","volume":"27","author":"Duffield","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ki.2010.154","article-title":"A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy","volume":"78","author":"Pang","year":"2010","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem Biol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B13","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-linked Alport syndrome","volume":"15","author":"Rheault","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B14","doi-asserted-by":"crossref","first-page":"e0128330","DOI":"10.1371\/journal.pone.0128330","article-title":"Superovulation using the combined administration of inhibin antiserum and equine chorionic gonadotropin increases the number of ovulated oocytes in C57BL\/6 female mice","volume":"10","author":"Takeo","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B15","doi-asserted-by":"crossref","first-page":"e43852","DOI":"10.1371\/journal.pone.0043852","article-title":"Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndrome","volume":"7","author":"Koga","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B16","doi-asserted-by":"crossref","first-page":"26143","DOI":"10.1074\/jbc.M114.580209","article-title":"The transcription factor MEF\/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism","volume":"289","author":"Suico","year":"2014","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1681\/ASN.2014111109","article-title":"Podocyte p53 limits the severity of experimental Alport syndrome","volume":"27","author":"Fukuda","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1440-1797.2012.01619.x","article-title":"Podocyte culture: tricks of the trade","volume":"17","author":"Ni","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B20","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1681\/ASN.2015091014","article-title":"Stat3 controls tubulointerstitial communication during CKD","volume":"27","author":"Bienaime","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","article-title":"STAT3 target genes relevant to human cancers","volume":"6","author":"Carpenter","year":"2014","journal-title":"Cancers (Basel)"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clim.2015.04.004","article-title":"Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL\/lpr mice","volume":"158","author":"Edwards","year":"2015","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B23","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s10157-017-1386-9","article-title":"Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model","volume":"21","author":"Omachi","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20120252","article-title":"Role of the TGF-beta\/BMP-7\/Smad pathways in renal diseases","volume":"124","author":"Meng","year":"2013","journal-title":"Clin Sci"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/labinvest.2014.81","article-title":"Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 dysregulation in lungs of fibrosis-resistant BALB\/c mice","volume":"94","author":"Wong","year":"2014","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000108102","article-title":"Inhibition of Jak\/STAT signaling ameliorates mice experimental nephrotic syndrome","volume":"27","author":"Li","year":"2007","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B28","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ddmec.2013.03.001","article-title":"STAT3 signaling in polycystic kidney disease","volume":"10","author":"Weimbs","year":"2013","journal-title":"Drug Discov Today Dis Mech"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ki.2009.98","article-title":"Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy","volume":"76","author":"Lu","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B30","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1038\/sj.onc.1205426","article-title":"p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3","volume":"21","author":"Lin","year":"2002","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2016.03.010","article-title":"Loss of P53 function activates JAK2-STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient survival","volume":"151","author":"Wormann","year":"2016","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B32","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1128\/MCB.25.17.7432-7440.2005","article-title":"Role of Stat3 in regulating p53 expression and function","volume":"25","author":"Niu","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20180328162557_gfx246-B33","doi-asserted-by":"crossref","first-page":"e87446","DOI":"10.1172\/jci.insight.87446","article-title":"Pentraxin-2 suppresses c-Jun\/AP-1 signaling to inhibit progressive fibrotic disease","volume":"1","author":"Nakagawa","year":"2016","journal-title":"JCI Insight"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/2\/214\/23748814\/gfx246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T03:42:34Z","timestamp":1659152554000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/2\/214\/4084310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,17]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx246","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,8,17]]}}}